Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Knox

Showing results (621-630 of 829) with videos related to

Pageof 83
Sort By:
International Journal of Radiation Biology|January 4, 2019
Development of a biodosimeter for radiation triage using novel blood protein biomarker panels in humans and non-human primatesRobert P Balog, Rowena Bacher, Polly Chang, et al.
Journal of the National Cancer Institute|May 31, 2014
Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysisArnoud J Templeton, Mairéad G McNamara, Boštjan Šeruga, et al.
Journal of Hepatology|May 5, 2015
Sofosbuvir plus ribavirin for treating Egyptian patients with hepatitis C genotype 4Wahid Doss, Gamal Shiha, Mohamed Hassany, et al.
International Journal of Radiation Oncology, Biology, Physics|March 6, 2004
A novel antiangiogenesis therapy using an integrin antagonist or anti-Flk-1 antibody coated 90Y-labeled nanoparticlesLingyun Li, Charles A Wartchow, S Narasimhan Danthi, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|August 30, 2008
Improving observer variability in target delineation for gastro-oesophageal cancer--the role of (18F)fluoro-2-deoxy-D-glucose positron emission tomography/computed tomographyD Vesprini, Y Ung, R Dinniwell, et al.
Physical Therapy|November 9, 2021
The Manual Therapy and Strengthening for the Hip (MASH) Trial: Protocol for a Multisite Randomized Trial of a Subgroup of Older Adults With Chronic Back and Hip PainJenifer M Pugliese, Peter C Coyle, Patrick J Knox, et al.
Cancer Biotherapy & Radiopharmaceuticals|August 22, 2006
Phase I study of 131I-chimeric(ch) TNT-1/B monoclonal antibody for the treatment of advanced colon cancerHilary Hardy Street, Michael L Goris, George Albert Fisher, et al.
Urology|March 13, 2010
Clinical outcome in metastatic renal cell carcinoma patients after failure of initial vascular endothelial growth factor-targeted therapyMichael M Vickers, Toni K Choueiri, Miranda Rogers, et al.
Current Oncology (Toronto, Ont.)|August 11, 2010
Adjuvant chemoradiation for gastric cancer with infusional 5-fluorouracil and cisplatin: a phase I studyZ Kassam, H Mackay, C A Buckley, et al.
Cancer Medicine|May 8, 2020
Second-line treatment of hepatocellular carcinoma after sorafenib: Characterizing treatments used over the past 10 years and real-world eligibility for cabozantinib, regorafenib, and ramucirumabAndrea S Fung, Vincent C Tam, Daniel E Meyers, et al.
Pageof 83

Showing results (621-630 of 829) with videos related to

Sort By:
Pageof 83
International Journal of Radiation Biology|January 4, 2019
Development of a biodosimeter for radiation triage using novel blood protein biomarker panels in humans and non-human primatesRobert P Balog, Rowena Bacher, Polly Chang, et al.
Journal of the National Cancer Institute|May 31, 2014
Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysisArnoud J Templeton, Mairéad G McNamara, Boštjan Šeruga, et al.
Journal of Hepatology|May 5, 2015
Sofosbuvir plus ribavirin for treating Egyptian patients with hepatitis C genotype 4Wahid Doss, Gamal Shiha, Mohamed Hassany, et al.
International Journal of Radiation Oncology, Biology, Physics|March 6, 2004
A novel antiangiogenesis therapy using an integrin antagonist or anti-Flk-1 antibody coated 90Y-labeled nanoparticlesLingyun Li, Charles A Wartchow, S Narasimhan Danthi, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|August 30, 2008
Improving observer variability in target delineation for gastro-oesophageal cancer--the role of (18F)fluoro-2-deoxy-D-glucose positron emission tomography/computed tomographyD Vesprini, Y Ung, R Dinniwell, et al.
Physical Therapy|November 9, 2021
The Manual Therapy and Strengthening for the Hip (MASH) Trial: Protocol for a Multisite Randomized Trial of a Subgroup of Older Adults With Chronic Back and Hip PainJenifer M Pugliese, Peter C Coyle, Patrick J Knox, et al.
Cancer Biotherapy & Radiopharmaceuticals|August 22, 2006
Phase I study of 131I-chimeric(ch) TNT-1/B monoclonal antibody for the treatment of advanced colon cancerHilary Hardy Street, Michael L Goris, George Albert Fisher, et al.
Urology|March 13, 2010
Clinical outcome in metastatic renal cell carcinoma patients after failure of initial vascular endothelial growth factor-targeted therapyMichael M Vickers, Toni K Choueiri, Miranda Rogers, et al.
Current Oncology (Toronto, Ont.)|August 11, 2010
Adjuvant chemoradiation for gastric cancer with infusional 5-fluorouracil and cisplatin: a phase I studyZ Kassam, H Mackay, C A Buckley, et al.
Cancer Medicine|May 8, 2020
Second-line treatment of hepatocellular carcinoma after sorafenib: Characterizing treatments used over the past 10 years and real-world eligibility for cabozantinib, regorafenib, and ramucirumabAndrea S Fung, Vincent C Tam, Daniel E Meyers, et al.
Pageof 83